Eicosapentaenoic acid decreases inflammation and improves glucose homeostasis in patients with burns: a randomized clinical trial
Abstract
Burn is accompanied by metabolic changes. The effects of fish oil on inflammatory pathways and glucose homeostasis have been reported in the previous studies. Various forms of omega-3 fatty acids affect differently the metabolic pathways. The present study was designed to investigate the effects of fish oil containing 500 mg eicosapentanoic acid (EPA) on inflammatory markers and glucose homeostasis in patients with non-severe burns. In this prospective double-blinded parallel-design randomized clinical trial, twenty-four patients with non-severe burns covering lower than 20% of total body surface area were divided into the fish oil (1.5 gr/d EPA and 600 mg/d DHA) or controls (1.5 gr/d corn oil and 600 mg/d DHA) for three weeks. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fasting blood sugar (FBS), albumin, pre-albumin (PAB), transferrin, and insulin concentration were measured at baseline and end. The homeostatic model assessment for insulin resistance (HOMA-IR) was computed. The duration of hospital stay was assessed as the secondary outcome. The reduction in serum ESR and CRP levels was significantly higher in the fish oil group than the controls (p < 0.001). Moreover, serum fasting insulin significantly decreased in the fish oil group (p < 0.001). Insulin sensitivity significantly improved in the fish oil compared to the controls (p = 0.001). The duration of hospital stay showed no significant difference between the two groups. The most enormous…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.